Abstract:Parkinson's disease (PD) has been recently associated with the excessive expression of matrix metalloproteinase 3 (MMP3). One of the major challenges in treating PD is to effectively detect and inhibit the early MMP3 activities to relieve the neural stress and inflammation responses. Previously, numerous upconversion nanoparticle (UCNP)-based nanoprobes have been designed for the detection of biomarkers in neurodegenerative diseases. To further improve the performance of the conventional nanoprobes, we introduced novel reporting units and integrated the therapeutic reagents to fabricate a theragnostic platform for PD and other neurodegenerative diseases. Here, we designed a multifunctional UCNP/aggregation-induced emission luminogen (AIEgen)-based nanoprobe to effectively detect the time-lapse MMP3 activities in the inflammatory catecholaminergic SH-SY5Y cells and simultaneously deliver the MMP3-siRNA into the stressed catecholaminergic SH-SY5Y cells, inhibiting the MMP3-induced inflammatory neural responses. The unique features of our UCNP/AIEgen-based nanoprobe platform shed light on the development of a novel theragnostic probe for the early diagnosis and cure of neurodegenerative diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c22112?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c22112</a>.Concentrations of the staining reagents, quantification method of fluorescence intensity, detection of MMP3 enzyme activity by AIEgen-peptide reporting units in PBS, FTIR spectra of the nanoprobe, size stability and MMP3 detection ability of the nanoprobe in biological environments, MMP detection in PBS and serum, western blotting results, examination of the Hemi-Parkinsonian mouse model after 6-OHDA injection,, and the sequences of PD-related primers and siRNA applied in the experiments (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c22112/suppl_file/am0c22112_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Activatable Organic Upconversion Nanoprobe for Bioimaging of Monoamine Oxidase B in Parkinson's Disease

Activatable Organic Upconversion Nanoprobe for Bioimaging of Monoamine Oxidase B in Parkinson’s Disease

A Small-Molecule Probe For Selective Profiling And Imaging Of Monoamine Oxidaseb Activities In Models Of Parkinson'S Disease

A Small‐Molecule Probe for Selective Profiling and Imaging of Monoamine Oxidase B Activities in Models of Parkinson’s Disease

An activity-based fluorogenic probe for sensitive and selective monoamine oxidase-B detection.

Visualization of monoamine oxidases in living cells using &quot;Turn-ON&quot; fluorescence resonance energy transfer probes.

A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models

Structure-Based Specific Detection And Inhibition Of Monoamine Oxidases And Their Applications In Central Nervous System Diseases

Near-Infrared Fluorescence Probe for Monoamine Oxidase A with a Large Stokes Shift for Intraoperative Navigation.

Mitochondrial-Targeted and Near-Infrared Fluorescence Probe for Bioimaging and Evaluating Monoamine Oxidase A Activity in Hepatic Fibrosis.

Novel Strategy of Constructing Fluorescent Probe for MAO-B Via Cascade Reaction and Its Application in Imaging MAO-B in Human Astrocyte

De Novo Design of a Robust Fluorescent Probe for Basal HClO Imaging in a Mouse Parkinson’s Disease Model

A Fluorogenic-Inhibitor-based Probe for Profiling and Imaging of Monoamine Oxidase A in Live Human Glioma Cells and Clinical Tissues

Multifunctional Nanoprobe for the Delivery of Therapeutic Sirna and Real-Time Molecular Imaging of Parkinson's Disease Biomarkers.

Rational Design of a Two‐Photon Fluorogenic Probe for Visualizing Monoamine Oxidase A Activity in Human Glioma Tissues

Deep-red Fluorogenic Probe for Rapid Detection of Nitric Oxide in Parkinson’s Disease Models

Inhibitor Structure-Guided Design and Synthesis of Near-Infrared Fluorescent Probes for Monoamine Oxidase A (MAO-A) and Its Application in Living Cells and in Vivo

Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson’s Disease Biomarkers

Monoamine oxidase A probe synthesis and fluorescence imaging in cells and zebrafish based on AIE mechanism

Design of an Activatable NIR-II Nanoprobe for the in Vivo Elucidation of Alzheimer's Disease-Related Variations in Methylglyoxal Concentrations.

Ratiometric Near-Infrared Fluorescent Probe for Synergistic Detection of Monoamine Oxidase B and Its Contribution to Oxidative Stress in Cell and Mice Aging Models